Global and China Fc Fusion Protein Market Insights, Forecast to 2027

Global and China Fc Fusion Protein Market Insights, Forecast to 2027

  • QYResearch
  • September 2021
  • Pharmaceutical
  • 141 pages

Report Description

Fc fusion protein is composed of the Fc segment of immunoglobulin and protein molecules with biological activity. The Fc segment and the functional protein have relatively independent structural domains and functions, which can affect the physical and chemical properties and biological activities of the fusion protein from different angles.
Fc-fusion proteins are bioengineered polypeptides that join the crystallizable fragment (Fc) domain of an antibody with another biologically active protein domain or peptide to generate a molecule with unique structurefunction properties and significant therapeutic potential. The gamma immunoglobulin (IgG) isotype is often used as the basis for generating Fc-fusion proteins

This report will focus on Fc fusion protein drugs.
Global Fc Fusion Protein market key players include Sanofi, Sobi, Eli Lilly and Company, etc., and the top 3 players hold about 70% of global shares. North America and Europe are main markets, they occupy about 90% of the global market. Brands drugs is the key type, with a share over 90%. Autoimmune disease and eye diseases are two main applications, they have over 60% shares altogther.

Market Analysis and Insights: Global and China Fc Fusion Protein Market
This report focuses on global and China Fc Fusion Protein market.
In 2020, the global Fc Fusion Protein market size was US$ 27020 million and it is expected to reach US$ 54290 million by the end of 2027, with a CAGR of 10.7% during 2021-2027. In China the Fc Fusion Protein market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Fc Fusion Protein Scope and Market Size
Fc Fusion Protein market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Fc Fusion Protein market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Fc Fusion Protein market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Brands Drugs
Biosimilar Drugs

Segment by Application
Autoimmune Disease
Eye Diseases
Diabetes
Hemophilia

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Sanofi
Bristol-Myers Squibb
Regeneron
Bayer
Amgen
Pfizer
Eli Lilly and Company
Sobi
Kanghong Pharma
3SBIO
Celgen Biopharma

Have query on this report?

Make an Enquiry
1 Study Coverage
1.1 Fc Fusion Protein Product Introduction
1.2 Market by Type
1.2.1 Global Fc Fusion Protein Market Size Growth Rate by Type
1.2.2 Brands Drugs
List of Tables
Table 1. Global Fc Fusion Protein Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Brands Drugs
Table 3. Major Manufacturers of Biosimilar Drugs
Table 4. Global Fc Fusion Protein Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Fc Fusion Protein Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027

Success Stories

Our Clients